Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Number of holders
-
479
-
Total 13F shares, excl. options
-
18,529,807
-
Shares change
-
-303,667
-
Total reported value, excl. options
-
$5,981,150,118
-
Value change
-
-$116,305,124
-
Put/Call ratio
-
59.31%
-
Number of buys
-
228
-
Number of sells
-
-237
-
Price
-
$322.89
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2023
564 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2023.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 479 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,529,807 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2,389,889 shares), BlackRock Inc. (1,466,264 shares), Veritas Asset Management LLP (1,082,895 shares), STATE STREET CORP (874,914 shares), UBS ASSET MANAGEMENT AMERICAS INC (503,208 shares), GEODE CAPITAL MANAGEMENT, LLC (460,086 shares), Invesco Ltd. (457,731 shares), ALLIANCEBERNSTEIN L.P. (441,702 shares), EARNEST PARTNERS LLC (393,634 shares), and BANK OF AMERICA CORP /DE/ (387,793 shares).
This table shows the top 479 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.